Skip to search formSkip to main contentSkip to account menu

Hyperlipidemia, Familial Combined

Known as: FCHL, Hyperlipidemias, Familial Combined, Multiple Lipoprotein-Type Hyperlipidemias 
A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes… 
National Institutes of Health

Related topics

Related topics

18 relations
Eyelid XanthomaHyperlipoproteinemia Type IIIHyperlipoproteinemia Type IIbHyperlipoproteinemia Type V

Narrower (2)

HYPERLIPIDEMIA, COMBINED, 1Hyperlipidemia, Combined, 2

Broader (1)

Hyperlipidemia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screening.
2008
2008
A PCSK9 variant and familial combined hyperlipidaemia
Background: Our discovery in 2003 of the first mutations of PCSK9 gene causing autosomal dominant hypercholesterolaemia (ADH… 
2004
2004
Contribution of Chromosome 1q21‐q23 to Familial Combined Hyperlipidemia in Mexican Families
Familial combined hyperlipidemia (FCHL) is the most common familial dyslipidemia, with a prevalence of 1‐2% in the general… 
Highly Cited
2003
Highly Cited
2003
Contribution of visceral adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance.
OBJECTIVE Impaired glucose tolerance (IGT) has been associated with alterations in numerous coronary heart disease risk factors… 
Highly Cited
1998
Highly Cited
1998
Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study
OBJECTIVE To compare the lipid-lowering efficacies of simvastatin and gemfibrozil in NIDDM patients with combined (mixed… 
Highly Cited
1994
Highly Cited
1994
Familial idiopathic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor.
Familial hypofibrinolysis with 3 generation, autosomal dominant, very high levels of plasminogen activator inhibitor activity… 
1993
1993
Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia
A sample enriched for familial combined hyperlipidemia (FCHL) was examined for evidence of an association between genotype at an… 
1991
1991
Lack of evidence for linkage between low‐density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia
Low‐density lipoprotein (LDL) subclass phenotype B, characterized by a predominance of small, dense LDL particles, appears to be… 
Highly Cited
1988
Highly Cited
1988
Combination drug therapy for familial combined hyperlipidemia.
STUDY OBJECTIVE To compare the efficacy of gemfibrozil and colestipol with gemfibrozil and lovastatin in patients with familial… 
Highly Cited
1983
Highly Cited
1983
Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia.
Hyperapobetalipoproteinemia is defined as the combination of a normal low density lipoprotein (LDL) cholesterol in the face of an… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)